Fig. 3. Key NOESY correlations of compounds 1, 2, 3 and 4.Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib, Rana Muhammad, Li, Guang-li, Hassan, Syed Shams ul, Yang, Zhi-hua, Xiao, Xue, Tu, Guo-li, Yan, Shi-Kai, Ma, Xian-peng & Jin, Hui-Zi, 2021, Guaiane-type sesquiterpenoids from Cinnamomum migao H. W. Li: And their anti-inflammatory activities, pp. 1-10 in Phytochemistry (112850) 190 on page 4, DOI: 10.1016/j.phytochem.2021.112850, http://zenodo.org/record/825787
Fig. 3. The key 1H–1H NOESY () correlations of compounds 1–8.Published as part of Li, Yahui, Liu, Ji...
Fig. 3. Key ROESY correlations of compounds 2–10.Published as part of Guo, Kai, Liu, Yan-Chun, Liu, ...
Fig. 2. 1H–1H COSY () and key 1H–13C HMBC () correlations of compounds 1–8.Published as part of Li, ...
Fig. 7. 1H–1H COSY and key HMBC correlations of compounds 9, 10, and 11.Published as part of Muhamma...
Fig. 4. CD spectrum of compounds 1 and 2.Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib, Ran...
Fig. 5. CD spectrum of compounds 3 and 4.Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib, Ran...
Fig. 1. Chemical structures of compounds 1–11.Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib...
Fig. 6. CD spectrum of compounds 5 and 6Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib, Rana...
Fig. 8. Inhibitory effect of compounds 1, 2, 3, 4, 5, 6, 7, 8, and 10 against the expression of pro-...
Muhammad, Ishaq, Luo, Wei, Shoaib, Rana Muhammad, Li, Guang-li, Hassan, Syed Shams ul, Yang, Zhi-hua...
Fig. 3. Key NOESY correlations of compounds 1–3.Published as part of Guo, Rui, Ren, Qiang, Tang, Ya-...
Fig. 2. Key HMBC correlations of compounds 1–3, 5–7 and the 1 H– 1 H COSY correlations of compounds ...
Fig. 3. Primary NOESY correlations for 1–6.Published as part of Cheng, Zhuo-Yang, Sun, Xue, Liu, Pin...
Fig. 6. The anti-inflammatory activity of compounds 1, 3, 4 and 10.Published as part of Li, Honglian...
Fig. 3. Selected NOESY correlations of compounds 1–9.Published as part of Ma, Chi Thanh, Ly, Tu Loan...
Fig. 3. The key 1H–1H NOESY () correlations of compounds 1–8.Published as part of Li, Yahui, Liu, Ji...
Fig. 3. Key ROESY correlations of compounds 2–10.Published as part of Guo, Kai, Liu, Yan-Chun, Liu, ...
Fig. 2. 1H–1H COSY () and key 1H–13C HMBC () correlations of compounds 1–8.Published as part of Li, ...
Fig. 7. 1H–1H COSY and key HMBC correlations of compounds 9, 10, and 11.Published as part of Muhamma...
Fig. 4. CD spectrum of compounds 1 and 2.Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib, Ran...
Fig. 5. CD spectrum of compounds 3 and 4.Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib, Ran...
Fig. 1. Chemical structures of compounds 1–11.Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib...
Fig. 6. CD spectrum of compounds 5 and 6Published as part of Muhammad, Ishaq, Luo, Wei, Shoaib, Rana...
Fig. 8. Inhibitory effect of compounds 1, 2, 3, 4, 5, 6, 7, 8, and 10 against the expression of pro-...
Muhammad, Ishaq, Luo, Wei, Shoaib, Rana Muhammad, Li, Guang-li, Hassan, Syed Shams ul, Yang, Zhi-hua...
Fig. 3. Key NOESY correlations of compounds 1–3.Published as part of Guo, Rui, Ren, Qiang, Tang, Ya-...
Fig. 2. Key HMBC correlations of compounds 1–3, 5–7 and the 1 H– 1 H COSY correlations of compounds ...
Fig. 3. Primary NOESY correlations for 1–6.Published as part of Cheng, Zhuo-Yang, Sun, Xue, Liu, Pin...
Fig. 6. The anti-inflammatory activity of compounds 1, 3, 4 and 10.Published as part of Li, Honglian...
Fig. 3. Selected NOESY correlations of compounds 1–9.Published as part of Ma, Chi Thanh, Ly, Tu Loan...
Fig. 3. The key 1H–1H NOESY () correlations of compounds 1–8.Published as part of Li, Yahui, Liu, Ji...
Fig. 3. Key ROESY correlations of compounds 2–10.Published as part of Guo, Kai, Liu, Yan-Chun, Liu, ...
Fig. 2. 1H–1H COSY () and key 1H–13C HMBC () correlations of compounds 1–8.Published as part of Li, ...